BioLargo (US: BLGO)

Last close As at 22/05/2024

0.27

0.00 (0.00%)

Market capitalisation

70m

Edison Investment Research is terminating coverage on BioLargo. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Healthcare | QuickView

BioLargo — Firing on all cylinders

Healthcare | QuickView

BioLargo — Clyraguard to be a major growth driver

Healthcare | QuickView

BioLargo — Clyra launches Clyraguard

Healthcare | QuickView

BioLargo — A record-setting year

Share Price Performance

Financials

Edison Investment Research is terminating coverage on BioLargo. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Research

QuickView

Healthcare

BioLargo — A record-setting year

QuickView

Healthcare

BioLargo — Record revenue and segment progress

QuickView

Healthcare

BioLargo — Clyra gets 510(k) clearance

QuickView

Healthcare

BioLargo — Progress towards independent businesses

QuickView

Healthcare

BioLargo — Guidance: Odor-No-More break-even by YE19

QuickView

Healthcare

BioLargo — Moving on multiple fronts

Update

Healthcare

BioLargo — Incubating innovation in iodine

Thematics

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

thematic

Healthcare

ASCO 2023 key takeaways

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free